W. West China

West China-Frontier PharmaTech (WCFP) is a leading Chinese contract research organization (CRO) specializing in non-clinical safety evaluation and drug development services. Established as the National Chengdu GLP Center, the company provides a comprehensive suite of services including toxicology, pharmacokinetics, pharmacodynamics, and bioanalytical testing. WCFP is notable for being one of the first GLP-compliant facilities in China to receive recognition from both the NMPA and international regulatory bodies like the OECD. The company supports a wide range of therapeutic modalities, including small molecules, biologics, and advanced therapies such as cell and gene products. By bridging academic research from Sichuan University with industrial drug development, WCFP plays a critical role in the Chinese pharmaceutical innovation ecosystem.